TEMESTA |
NSC-289758 |
LORAZEPAM INTENSOL |
LORAZEPAM PRESERVATIVE FREE |
LORAZEPAM CIV |
LORAZ |
LORAZEPAM |
WY-4036 |
ATIVAN |
ABBLORAZ |
O-CHLOROOXAZEPAM |
ATIVAN® |
(±)-LORAZEPAM |
METHYLLORAZEPAM |
O-CHLOROXAZEPAM |
LORMETAZEPAM |
ORFIDAL® |
N-METHYLLORAZEPAM |
chemidplus:846-49-1 |
chembl:CHEMBL580 |
rxcui:6470 |
drugbank:00186 |
pubchem.compound:3958 |
FDA Approval | 1977 |
Drug Class | small molecule |
Drug Indications | Hypnotics and Sedatives |
Drug Indications | Anticonvulsants |
Drug Indications | Anti-anxiety Agents |
Drug Class | anticonvulsants |
Drug Class | hypnotics and sedatives |
Drug Class | anti-anxiety agents |
Year of Approval | 1977 |
n/a |
Novel drug target | Established target |
Trial Name | - |
n/a |
Trial Name | - |
Novel drug target | Established target |
n/a |
Novel drug target | Established target |
Trial Name | - |
ligand |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
Trial Name | - |
positive modulator (activating) |
Trial Name | - |
Novel drug target | Established target |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
Trial Name | - |
positive modulator (activating) |
Direct Interaction | yes |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Trial Name | - |
positive modulator (activating) |
Trial Name | - |
Novel drug target | Established target |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
Trial Name | - |
Novel drug target | Established target |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
Novel drug target | Established target |
Trial Name | - |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
Novel drug target | Established target |
Trial Name | - |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
Trial Name | - |
Novel drug target | Established target |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
Novel drug target | Established target |
Trial Name | - |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
Trial Name | - |
positive modulator (activating) |
Trial Name | - |
Novel drug target | Established target |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
Trial Name | - |
Novel drug target | Established target |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
Trial Name | - |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
Trial Name | - |
positive modulator (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel positive allosteric modulator |
Direct Interaction | yes |
Year of Approval | 1977 |
Drug Class | anti-anxiety agents |
Drug Class | hypnotics and sedatives |
Drug Indications | Anti-anxiety Agents |
Drug Indications | Anticonvulsants |
Drug Indications | Hypnotics and Sedatives |
C619 | NCI drug code |
D0E0OG | TTD Drug ID |